NEW YORK (GenomeWeb News) – The Women and Infants Hospital of Rhode Island will be using funding from genetic testing firm Natera to study the use of the company's prenatal blood test for Down syndrome and other chromosomal abnormalities in a general clinical setting.

Investigators at the hospital plan to focus their efforts on finding out how much information and education women in the general pregnancy population need about the test, called Panorama, which has been used so far been used to screen women in high-risk groups, the hospital said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.